| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 03/08/2001 | DE19937537A1 Substituierte 2-Dialkylaminoalkylbiphenyl-Derivate 2-substituted derivatives Dialkylaminoalkylbiphenyl |
| 03/08/2001 | CA2488370A1 Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events |
| 03/08/2001 | CA2403243A1 Nucleic acid based modulators of gene expression |
| 03/08/2001 | CA2388560A1 Sustained-release form of administration containing tramadol saccharinate |
| 03/08/2001 | CA2384194A1 Benzylidene-thiazolidinediones and analogues and their use in the treatment of inflammation |
| 03/08/2001 | CA2384126A1 Reverse-turn mimetics and methods relating thereto |
| 03/08/2001 | CA2384055A1 Compositions and methods for the treatment of immune related diseases |
| 03/08/2001 | CA2384026A1 Dna encoding a human subunit 5-ht3-c of the 5-ht3 serotonin receptor |
| 03/08/2001 | CA2383783A1 Use of bis-sulfonamides for producing medicaments used for preventing or treating hyperlipidaemia |
| 03/08/2001 | CA2383781A1 Sulfonyl carboxamide derivatives, method for their production and their use as medicaments |
| 03/08/2001 | CA2383693A1 Card proteins involved in cell death regulation |
| 03/08/2001 | CA2383603A1 Method of identifying inhibitors of cdc25 |
| 03/08/2001 | CA2383367A1 Prevention of myocarditis, abortion and intrauterine infection associated with porcine circovirus-2 |
| 03/08/2001 | CA2383347A1 Benzylidene-thiazolidinediones and analogues and their use in the treatment of diabetes |
| 03/08/2001 | CA2383329A1 4,5-diaryloxazole compounds with prostaglandin 12 (pg12) agonistic activity |
| 03/08/2001 | CA2383002A1 Substituted .alpha.-hydroxy acid caspase inhibitors and the use thereof |
| 03/08/2001 | CA2382966A1 Biaryl-oxa(thia)zole derivatives and their use as ppars modulators |
| 03/08/2001 | CA2382562A1 Compositions and methods for modulating hdl cholesterol and triglyceride levels |
| 03/08/2001 | CA2382449A1 Metal-containing compositions, preparations and uses |
| 03/08/2001 | CA2382427A1 Uses of diterpenoid triepoxides as an anti-proliferative agent |
| 03/08/2001 | CA2382345A1 Extended duration light activated cancer therapy |
| 03/08/2001 | CA2382303A1 Methods of and compositions for inhibiting the proliferation of mammalian cells |
| 03/08/2001 | CA2381926A1 Systemic inflammatory markers as diagnostic tools in the prevention of atherosclerotic diseases |
| 03/07/2001 | EP1081155A2 N6 heterocyclic substituted adenosine derivatives |
| 03/07/2001 | EP1081144A2 Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems |
| 03/07/2001 | EP1081143A1 Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems |
| 03/07/2001 | EP1081137A1 Selective inhibitors of aggrecanase in osteoarthritis treatment |
| 03/07/2001 | EP1081135A2 1H-indole-3-glyoxylamide spla2 inhibitors |
| 03/07/2001 | EP1080233A1 Compounds, screening methods, and uses involving anti-apoptotic genes and gene products |
| 03/07/2001 | EP1080194A2 Human transmembrane proteins |
| 03/07/2001 | EP1080180A2 Secreted proteins and polynucleotides encoding them |
| 03/07/2001 | EP1080092A2 Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation |
| 03/07/2001 | EP1080087A1 Novel 2-alkyl substituted imidazole compounds |
| 03/07/2001 | EP1080083A1 Novel heterocyclically substituted amides with cysteine protease-inhibiting effect |
| 03/07/2001 | EP1080081A1 Benzofuroxan derivatives and their use in treating angina pectoris |
| 03/07/2001 | EP1080080A1 Novel therapeutic agents that modulate neurokinin receptors |
| 03/07/2001 | EP1080078A1 Heterocyclic compounds and methods to treat cardiac failure and other disorders |
| 03/07/2001 | EP1080075A1 Piperididinyl and n-amidinopiperidinyl derivatives |
| 03/07/2001 | EP1080074A1 New heterocyclically substituted amides, their production and their use |
| 03/07/2001 | EP1080073A1 Compositions comprising 2-phenyl-indole compounds and estrogen formulations |
| 03/07/2001 | EP1080069A1 Anthranilic acid derivatives as inhibitors of the cgmp-phosphodiesterase |
| 03/07/2001 | EP1079852A1 Composition based on pentoxifylline and anticytokin |
| 03/07/2001 | EP1079848A1 Angiostatin receptor |
| 03/07/2001 | EP1079834A1 Stabile compositions comprising levosimendan and alginic acid |
| 03/07/2001 | EP1079829A1 Use of benzofuroxan derivatives in treating angina pectoris |
| 03/07/2001 | EP1079826A2 Use of indigoid bisindole derivatives for the manufacture of a medicament to inhibit cyclin dependent kinases |
| 03/07/2001 | EP1079825A2 Compounds that inhibit the binding of integrins to their receptors |
| 03/07/2001 | EP1079822A1 Composition containing polyacrylate, polyterpene, nitroglycerine and possibly polyvinyl acetate |
| 03/07/2001 | EP1079813A2 Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces |
| 03/07/2001 | EP1079811A1 Biodegradable sustained-release alginate gels |
| 03/07/2001 | EP1079792A2 Compositions and methods for inhibiting endothelial cell proliferation and regulating angiogenesis using serine proteases |
| 03/07/2001 | EP1079763A2 Serotonergic 5ht 7? receptor compounds for treating ocular and cns disorders |
| 03/07/2001 | EP0847276B1 Method for effecting vasodilation with (1,5-inter)aryl prostaglandin derivatives |
| 03/07/2001 | EP0625969B1 Arylalkoxyphenoxy-imidazoline compounds |
| 03/07/2001 | CN1286695A Process for preparation of N2-(1 (s)-carboxy-3-phenylpropyl)-L-lysyl-L-proline |
| 03/07/2001 | CN1286633A Use of ketolides for preparing arterial thrombotic complications related to atherosclerosis |
| 03/07/2001 | CN1286251A Method for preparing 5-lipooxygenase inhibitor having changeable heterocycle system |
| 03/07/2001 | CN1286250A Method for preparing 5-lipooxygenase inhibitor having changeable heterocycle system |
| 03/07/2001 | CN1286111A Chinese-medicinal prescription for lowering blood pressure |
| 03/07/2001 | CN1286092A Medicine for eliminating thrombus and treating apoplexy |
| 03/07/2001 | CN1062859C Substd 1-naphthoyl guanidines, their preparing method, use and drug contg. them |
| 03/07/2001 | CN1062858C Phenyl-substd alkenylcarboguanidides carrying perfluoroalkyl groups, process for their preparation, their use as medicament and medicines |
| 03/06/2001 | US6197982 Vitamin D analogues |
| 03/06/2001 | US6197959 Piperidine derivatives |
| 03/06/2001 | US6197958 Carboxylic acid derivatives, their preparation and use |
| 03/06/2001 | US6197931 Human marco scavenger receptor |
| 03/06/2001 | US6197828 Derivatives of (+)-venlafaxine and methods of preparing and using the same |
| 03/06/2001 | US6197824 Benzamidine derivatives and the use thereof as medicaments with LTB4-antagonistic effect |
| 03/06/2001 | US6197822 Neuropeptide antagonists |
| 03/06/2001 | US6197811 Synthetic derivatives of phomalactone, a known compound obtainable by fermentation of the fungus phomopsis sp, have activity as inhibitors of cytokine production in treatment of disorders requiring immunosuppression, for example |
| 03/06/2001 | US6197810 3-(arylsulfonylamino)-tetrahydropyran-3-carboxylic acid hydroxamides |
| 03/06/2001 | US6197800 Hypotensive agents; cardiovascular disorders |
| 03/06/2001 | US6197789 Antidiabetic agents |
| 03/06/2001 | US6197786 Anticholesterol agents |
| 03/06/2001 | US6197785 Cardiovascular disorders |
| 03/06/2001 | US6197782 Therapy for sexual disorders |
| 03/06/2001 | US6197780 Administering an endothelin anatgonist |
| 03/06/2001 | US6197778 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
| 03/06/2001 | US6197773 N-acyl and N-aroyl aralkyl amides as serotonergic agents |
| 03/06/2001 | US6197769 Serotonine receptors antagonist; gastrointestinal disorders, antiarrhythmia agents; incontinence |
| 03/06/2001 | US6197752 Tetrahydrofuran or tetrahydropyran compound; therapy for autoimmune disease, antiallergens, antiinflammatory agents |
| 03/06/2001 | US6197750 C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |
| 03/06/2001 | US6197748 Ketoheterocyclic inhibitors of factor Xa |
| 03/06/2001 | US6197745 Methods for producing nitrosated hemoglobins and therapeutic uses therefor |
| 03/06/2001 | US6197581 Human adenylate cyclase and use therefor |
| 03/06/2001 | US6197541 Nucleic acid which codes for mammalian receptor having seven transmembrane domains; drug screening of anticoagulants and wound healing agents; diagnosis of cardiovascular disorders; treatment of restenosis and unstable angina |
| 03/06/2001 | US6197505 Nucleic acid derived from human gene which encodes angiotensin converting enzyme and which is polymorphic at one or several positions; screening for predisposition; assessing responsiveness of individual to treatment regimen |
| 03/06/2001 | US6197324 Implanting local anesthetic into myocardial tissue |
| 03/06/2001 | US6197294 Cells containing recombinant polynucleotides coding for cell surface molecules that, when expressed in the cell, result in rejection of the cell by host cell by host immune system; useful for gene therapy |
| 03/06/2001 | US6197069 Adrenomedullin receptor polynucleotides |
| 03/06/2001 | CA1341196C Process for the preparation of substituted imino diacids |
| 03/01/2001 | WO2001014581A2 Hdac4 and hdac5 in the regulation of cardiac gene expression |
| 03/01/2001 | WO2001014564A2 Polynucleotides expressed in activated t-lymphocytes and proteins encoded thereby |
| 03/01/2001 | WO2001014557A1 Pd-1, a receptor for b7-4, and uses therefor |
| 03/01/2001 | WO2001014554A1 G protein-coupled receptor expressed in brain |
| 03/01/2001 | WO2001014549A1 Gas1 polypeptides |
| 03/01/2001 | WO2001014548A2 New g-protein coupled receptor and dna sequences thereof |
| 03/01/2001 | WO2001014418A2 p193 PROTEINS AND NUCLEIC ACIDS, AND USES THEREOF |
| 03/01/2001 | WO2001014415A2 Egfh2 genes and gene products |
| 03/01/2001 | WO2001014405A2 Methods of obtaining 2-methoxyestradiol of high purity |